PTPRJ and neoplasm: We also know from investigations of the relationship between PTPRJ and EGFR, that one proposed tumour suppressive mechanism for DEP-1 is the inactivation and retention of EGFR at the cell membrane and therefore the abrogation of EGF-induced signaling [16].